TETRAKIS(1-((4-TERT-BUTYLPHENYLSULFONYL&(183800-15-9)
- Name: TETRAKIS(1-((4-TERT-BUTYLPHENYLSULFONYL&
- Synonyms:Rhodium,tetrakis[m-[1-[[4-(1,1-dimethylethyl)phenyl]sulfonyl]-D-prolinato-O2:O2']]di-,(Rh-Rh)
- Molecular Formula:C60H80 N4 O16 Rh2 S4
- Molecular Weight:1447.39
- CAS Registry Number:183800-15-9
- EINECS:
- Melting Point:>300 °C(lit.)
- Water Solubility:
CAS No.183800-15-9 TETRAKIS(1-((4-TERT-BUTYLPHENYLSULFONYL&
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.183800-15-9 Tetrakis[1-[(4-tert-butylphenyl)sulfonyl]-(2R)-pyrrolidinecarboxylate]dirhodium(II)
Assay:95% Application:For research use only.
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 183901-63-5/.alpha.-D-Mannopyranose, 2,3,4,6-tetrabenzoate 1-(2,2,2-trichloroethanimidate)
- 183897-90-7/Benzoic acid, 3-methoxy-, propyl ester (9CI)
- 183890-34-8/2-Piperidinecarboxylicacid,6-oxo-,methylester,(2R)-(9CI)
- 183873-86-1/6-Oxa-2-azabicyclo[3.2.0]heptane-3,7-dione,1-(hydroxymethyl)-,(1R)-(9CI)
- 183873-64-5/Piperazine, 1,4-bis[(trimethylsilyl)methyl]- (9CI)
- 183870-67-9/1,4-Benzenediamine, 2-nitro-, labeled with carbon-14 (9CI)
- 183864-43-9/1-Propen-1-amine,N-(4-pyridinylmethylene)-(9CI)
- 183864-41-7/1-Propen-1-amine,N-(3-pyridinylmethylene)-,(Z,E)-(9CI)
- 183864-39-3/1-Propen-1-amine,N-(3-pyridinylmethylene)-(9CI)
- 183864-22-4/2-Propen-1-amine,N-(4-pyridinylmethylene)-,(E)-(9CI)
- 183864-21-3/2-Propen-1-amine,N-(3-pyridinylmethylene)-,(E)-(9CI)
- 183859-35-0/2-Piperidineaceticacid,alpha-amino-(9CI)
- 183815-52-3/Tasmannia lanceolata, ext.
- 183815-50-1/Siloxanes and Silicones, 3-(2-aminoethyl)aminopropyl methoxy, di-Me, Me methoxy, polymers with 3-(2-aminoethyl)aminopropyl Me silsesquioxanes, 3-(2-aminoethyl)aminopropyldimethoxysilyloxy- and (dimethoxymethylsilyl)oxy-terminated
- 183802-11-1/1H-Pyrrolo[1,2,3-de]quinoxaline-2,5(3H,6H)-dione(9CI)
- 183800-94-4/4-(TRIFLUOROMETHOXY)CINNAMIC ALDEHYDE
- 183800-15-9/TETRAKIS(1-((4-TERT-BUTYLPHENYLSULFONYL&
- 183800-06-8/8-Oxabicyclo[3.2.1]octa-2,6-diene-2-carboxylicacid,(1S)-(9CI)
- 183793-49-9/Carbamic acid, [(1R)-2-hydroxy-1-(methoxymethyl)ethyl]-, 1,1-dimethylethyl
- 183786-50-7/Cyclopentene, 1-(3-methoxy-1-propynyl)- (9CI)
- 183786-23-4/3-Piperidinecarboxylicacid,2-methyl-,methylester(9CI)
- 183745-82-6/AMYLOID BETA-PROTEIN (6-20)
- 183745-81-5/AMYLOID BETA-PROTEIN (1-15)
- 183744-46-9/1,3-Cyclopentanediol,4-(2-hydroxyethyl)-5-(hydroxymethyl)-1-methyl-,[1S-(1-alpha-,3-alpha-,4-bta-,5-bta-)]-(9CI)
- 183742-86-1/Cyclohexanone, 2,2-difluoro-3,3-dihydroxy-
- 183742-32-7/(1,4-Dibenzyl-piperazin-2-yl)-acetic acid methyl ester
- 183742-01-0/4-Pyridinecarboxylicacid,5-amino-1,2-dihydro-2-oxo-(9CI)
- 183741-86-8/5-(TERT-BUTOXYCARBONYLAMINO)-2-METHOXYPYRIDINE-4-CARBOXYLIC ACID
- 183739-65-3/Benzamide, 3-formyl-N-methyl- (9CI)
- 183721-15-5/9-CHLORO-2-(2-FURANYL)-5-[(PHENYLACETY)AMINO][1,2,4]-TRIAZOLO[1,5-C] QUINAZOLINE